With state of the art sterilization and mixing facilities, a comfortable lounge, and six doctors on staff, you can’t find a better place for IV hydration therapy.
Therapy with mistletoe products is used in a number of different ways and for a broad spectrum of tumour diseases. Within a treatment plan, it can have a supportive (adjuvant), alleviating (palliative) or, most commonly, a general strengthening and preventive character.
Although there are only a handful of hormones that we focus on for Bio-identical Hormone Replacement therapy (BHRT), there are many ways to apply these hormones. There are pills, patches, creams, gels, nasal sprays, sublinguals, suppositories, injections and pellets. There is a place for many of these applications and it is very patient specific, however some applications provide optimal response in the body more than others.
Eighty million adults are affected by heart disease (one in three people) and twenty-Five percent of deaths in the United States are due to heart disease. From 1999 to 2009, the cardiovascular disease death rate declined by 33%. However, cardiovascular disease still takes the lives of more than 2,150 Americans each day, an average of 1 death every 40 seconds and is still the number one cause of death. In 2010, coronary artery disease alone was projected to cost the United States $108.9 billion. Most heart attacks occur because of atherosclerotic plaque but, unfortunately, atherosclerosis often remains asymptomatic, delaying treatment until too late. Prevention is key!
Increasingly the scientific and medical community is becoming cognizant of the tremendous impact diet and lifestyle can have on inflammatory conditions such as heart disease, arthritis, autoimmune conditions and inflammatory bowel disease. For example, the American Heart Association (AHA) and the National Heart, Lung, and Blood Institute (NHLBI) have stated emphatically that the metabolic syndrome in adults should be treated first with diet and lifestyle therapy, rather than medications. The metabolic syndrome comprises a group of metabolic risk factors occurring in one person, including abdominal obesity, hypercholesterolemia, hypertension, insulin resistance, and pro-thrombotic and pro-inflammatory states.